YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.05 CNY | +3.43% |
|
-1.71% | -34.26% |
| 27/05 | Dongcheng Biochemicals' Unit Gets Nod to Trial Pancreatic Cancer Drug | MT |
| 20/05 | Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Approves the Cash Dividend for the Year 2023 | CI |
Chart calendar Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
7bc813f62b0a29e2ea93d47264.GUJIn5AHTiub0ffwzSbbvnEi7PIMBfGehI5NqAJB8gE.ay57yftCCwbC5b-6mnbs7D1VvMZgRsnz6OIvmUA5iEN2Nz7con8BEvqjkA~87468cea97a0c4d251023d78778aa9cb
Upcoming events on Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
Past events on Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
| 27/04/2024 | Q1 2024 Earnings Release |
| 27/04/2024 | Q4 2023 Earnings Release |
| 27/10/2023 | Q3 2023 Earnings Release |
| 24/08/2023 | Q2 2023 Earnings Release |
| 29/04/2023 | Q1 2023 Earnings Release |
| 29/04/2023 | Q4 2022 Earnings Release |
| 28/10/2022 | Q3 2022 Earnings Release |
| 26/08/2022 | Interim 2022 Earnings Release |
| 29/04/2022 | FY 2021 Earnings Release |
| 29/04/2022 | Q1 2022 Earnings Release |
| 29/10/2021 | Q3 2021 Earnings Release |
| 28/07/2021 | Interim 2021 Earnings Release |
| 30/04/2021 | FY 2020 Earnings Release |
| 30/04/2021 | Q1 2021 Earnings Release |
| 27/10/2020 | Q3 2020 Earnings Release |
| 07/08/2020 | Interim 2020 Earnings Release |
| 18/04/2020 | FY 2019 Earnings Release |
| 18/04/2020 | Q1 2020 Earnings Release |
| 05/03/2020 12:10 pm | Extraordinary Shareholders Meeting |
| 29/10/2019 | Q3 2019 Earnings Release |
Past dividends on Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
| 24/06/2024 | Annual 0.125 CNY |
| 10/07/2023 | Annual 0.15 CNY |
| 09/06/2022 | Annual 0.15 CNY |
| 04/06/2021 | Annual 0.25 CNY |
| 27/05/2020 | Annual 0.25 CNY |
| 24/04/2019 | Annual 0.048 CNY |
| 24/05/2018 | Annual 0.027 CNY |
| 16/06/2017 | Annual 0.04 CNY |
| 20/05/2016 | Annual 0.11 CNY |
| 15/05/2015 | 0.15 CNY |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 2 993 3 086 -3.02% | 3 419 3 918 -12.74% | 3 912 3 790 3.22% | 3 583 4 157 -13.81% | 3 276 3 507 -6.59% | 3 357 |
|
EBITDA Million CNY | Released Forecast Spread | 493 771 -36.08% | 715 977 -26.79% | 476 909 -47.59% | 579 925 -37.4% | 486 772 -37.09% | 720 |
|
EBIT Million CNY | Released Forecast Spread | 394 620 -36.49% | 609 826 -26.25% | 357 670 -46.73% | 448 695 -35.5% | 342 583 -41.42% | 470 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 396 620 -36.17% | 611 831 -26.43% | 356 672 -47.01% | 446 696 -35.96% | 337 584 -42.21% | 468 |
|
Net income Million CNY | Released Forecast Spread | 155 375 -58.74% | 418 427 -2.14% | 152 390 -61.14% | 307 397 -22.63% | 210 373 -43.78% | 300 |
|
EPS CNY | Released Forecast Spread | 0,19 0,60 -67.85% | 0,52 0,53 -1.74% | 0,19 0,49 -61.45% | 0,38 0,47 -19.06% | 0,25 0,45 -43.9% | 0,36 |
| Announcement Date | 21/02/20 | 29/04/21 | 28/04/22 | 28/04/23 | 26/04/24 | - |
More events
Past sector events for Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
| 28/05/2024 09:23 pm | WOCKHARDT LIMITED: Q4 2024 Earnings Release |
| 24/05/2024 08:24 pm | GLENMARK PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 22/05/2024 03:05 pm | SUN PHARMACEUTICAL INDUSTRIES LTD.: Q4 2024 Earnings Release |
| 22/05/2024 01:43 pm | STRIDES PHARMA SCIENCE LIMITED: Q4 2024 Earnings Release |
| 19/05/2024 12:16 pm | MIDDLE EAST PHARMACEUTICAL INDUSTRIES COMPANY: Q1 2024 Earnings Release |
| 17/05/2024 03:40 pm | ZYDUS LIFESCIENCES LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 01:55 pm | CAPLIN POINT LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 11:45 am | KRKA, D. D.: Q1 2024 Earnings Release |
| 16/05/2024 | SAM CHUN DANG PHARM. CO., LTD: Q1 2024 Earnings Release |
| 16/05/2024 | CELLTRION PHARM, INC.: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 002675 Stock
- Calendar Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
